L Xing, Y Liu, H Yao, T Wang, F Xie, S Luo… - Frontiers in …, 2022 - frontiersin.org
Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, has been well
studied in the treatment of endometriosis symptomatic. It is mainly metabolized by the …